- We’ve aggressively pursued international distribution opportunities
Clegg, a former Wairarapa farmer, as a direct sales marketer of nutritional, weight loss and energy products. In recent years the he has refocused to make colostrum and expanded into the biotech market, which included purchasing the rights to the world’s number one colostrum brand “Symbiotics” for Asia and Europe. Clegg says that the investment gave him a significant strategic advantage.
“What’s made us successful is that strategically we got it right. The second reason is because we’ve aggressively pursued international distribution opportunities – making 500 international flights in three years. You’ve got to go and talk to people.
New Image Asia, a direct sales company; BioActive, a wholesale product supplier; and Symbiotics, a colostrum focused biotech company.
Mr Clegg says the next three years will be very exciting with the rapid expansion of the colostrum market in Asia and Europe, the development of new categories, new suppliers and new competitors.
“We are determined to maintain our global leader positioning. We have focused on the biohealth sector of the biotech industry he has a competitive advantage. We have proven that you can create explosive growth and we believe that this will be our next billion dollar industry.”